99362-10-4

Basic information

• Product Name: N-(4-AMINO-BENZYL)-ACETAMIDE
• Synonyms: N-(4-AMINO-BENZYL)-ACETAMIDE;N-2-(4-AMINOPHENYL)ETHYL ACETAMIDE
• CAS NO: 99362-10-4
• Molecular Formula: C₉H₁₂N₂O
• Molecular Weight: 164.2
• Product Categories: Miscellaneous
• Mol File: 99362-10-4.mol
• Article Data: 11

Chemical Properties

• Boiling Point: 414.8 °C at 760 mmHg
• Flash Point: 204.7 °C
• Appearance: /
• Density: 1.117 g/cm³
• CAS DataBase Reference: N-(4-AMINO-BENZYL)-ACETAMIDE(CAS DataBase Reference)
• NIST Chemistry Reference: N-(4-AMINO-BENZYL)-ACETAMIDE(99362-10-4)
• EPA Substance Registry System: N-(4-AMINO-BENZYL)-ACETAMIDE(99362-10-4)

Safety Data

• Hazardous Substances Data: 99362-10-4(Hazardous Substances Data)

Usage

General Description

N-(4-AMINO-BENZYL)-ACETAMIDE is a chemical compound with the molecular formula C9H12N2O. It is a derivative of acetamide, with a benzyl group that contains an amino group at the 4th position. N-(4-AMINO-BENZYL)-ACETAMIDE has potential pharmacological properties and may have applications in medicinal chemistry. It is also used as an intermediate in the synthesis of various drugs and pharmaceuticals. N-(4-AMINO-BENZYL)-ACETAMIDE may have potential biological activity and could be further studied for its therapeutic potential in various medical treatments.

Upstream product

• 4403-71-8 (4-aminomethyl)aniline 
• 62133-07-7 2-(4-nitrobenzyl)-1H-isoindole-1,3(2H)-dione 
• 7409-30-5 p-nitrobenzylamine 
• 2735-73-1 1,3-diacetyl-1,3-dihydro-benzoimidazol-2-one 
• 108-24-7 acetic anhydride 
• 18600-42-5 4-nitrobenzylamine hydrochloride 
• 56222-10-7 N-(4-nitrobenzyl)acetamide 
• 141-78-6 ethyl acetate 
• 100-11-8 1-bromomethyl-4-nitro-benzene 
• 588-46-5 N-(phenylmethyl)acetamide 

Downstream Products

• 32479-21-3 N-acetamid 
• 32479-23-5 N-acetamid 
• 34185-04-1 N-(4-hydroxybenzyl)acetamide 
• 4403-71-8 (4-aminomethyl)aniline 
• 705256-52-6 ethyl N-{4-[(acetylamino)methyl]phenyl}glycinate 
• 1032638-76-8 C₂₀H₁₅Cl₂N₅O 
• 32478-93-6 N-p-Phenylazobenzylbernsteinsaeuremonoamid 
• 32478-94-7 N-p-Phenylazobenzylcaprylamid 
• 32479-05-3 N-(p-Phenylazobenzyl)harnstoff 
• 32478-92-5 N-p-Phenylazobenzylformamid 
• 32478-80-1 N-p-Chlorphenylazobenzyliden-4-biphenylamin 
• 32478-78-7 p-Tolylazobenzyliden-4-biphenylamin 
• 402508-93-4 tert-butyl (1R)-2-{4-[(acetylamino)methyl]anilino}-1-methylethyl-[(2R)-2-{[tert-butyl(dimethyl)silyl]oxy}-2-(3-chlorophenyl)ethyl]carbamate 
• 32479-09-7 C₁₄H₁₃N₃O₂*C₁₃H₁₃N₃ 

Relevant articles and documents

NAMPT MODULATORS

Provided are compounds of Formula (II) or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5, R6, and p are as defined herein. Also provided is a pharmaceutically acceptable composition comprising a compound of Formula (II), or a pharmaceutically acceptable salt thereof. Also provided are methods of using a compound of Formula (II), or a pharmaceutically acceptable salt thereof.

NOVEL FLUORESCENT KINASE LIGANDS AND ASSAYS EMPLOYING THE SAME

The case relates to novel fluorescent kinase ligands, and to methods for using the fluorescent ligands, singly or in combination, in the identification of further ligands for kinases. The invention also relates to kits comprising the fluorescent kinase ligands.

1H-INDAZOLE-3-CARBOXAMIDE COMPOUNDS AS MAPKAP KINASE MODULATORS

The invention provides compounds of the formula: (I) for use in the prophylaxis or treatment of a disease state or condition mediated by a MAPKAP kinase: wherein A is a bond or a group CH2; R1 is a carbocyclic or heterocyclic group having from 3 to 12 ring members; R3, R4, R5 and R6 are the same or different and are each selected from hydrogen, halogen, hydroxy, trifluoromethyl, cyano, nitro, carboxy, amino, carbocyclic and heterocyclic groups having from 3 to 12 ring members; a group Ra -Rbwherein Ra is a bond, 0, CO, X1C(X2), C(X2)Xl, X1C(X2)X1, S, SO, S02, NRc, SO2NRc or NRcS02; and Rb is selected from hydrogen, carbocyclic and heterocyclic groups having from 3 to 12 ring members, and a C1-8 hydrocarbyl group optionally substituted by one or more substituents selected from hydroxy, oxo, halogen, cyano, nitro, amino, mono or di-C1-4 hydrocarbylamino, carbocyclic and heterocyclic groups having from 3 to 12 ring members and wherein one or more carbon atoms of the C1-8 hydrocarbyl group may optionally be replaced by 0, S, SO, SO2, NRc, X1C(X2), C(X2)X1 or X1C(X2)X1; Rc is hydrogen or C1-4hydrocarbyl; and X1 is O, S or NRc and X2 is =O, =S or =NRc.